verapamil has been researched along with nicorandil in 34 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 12 (35.29) | 18.7374 |
| 1990's | 8 (23.53) | 18.2507 |
| 2000's | 10 (29.41) | 29.6817 |
| 2010's | 4 (11.76) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Satoh, K; Taira, N; Yanagisawa, T | 1 |
| Itoh, M; Miyamoto, T; Noguchi, Y; Yokochi, K | 1 |
| Fukuo, K; Imanaka, S; Kim, S; Kitano, S; Koh, E; Miyashita, Y; Morimoto, S; Morita, R; Ogihara, T | 1 |
| Abe, S; Hattori, S; Kojima, S; Miyamori, R; Miyazaki, T; Mori, H; Nakamura, Y; Sakurai, K; Takahashi, M | 1 |
| Hinohara, Y; Homma, N; Kuromaru, O; Sakai, K; Yamazaki, T | 1 |
| Fujiwara, M; Muramatsu, I | 1 |
| Hader, S; Leitold, M | 1 |
| Ikeda, K; Imai, S; Ito, M; Joh, T; Katsumi, K; Matsusako, K; Miyamoto, T; Takeuchi, T; Yasue, N; Yokoyama, Y | 1 |
| Kigoshi, S; Muramatsu, I; Nishio, M | 1 |
| Ishii, K; Satoh, K; Taira, N; Yanagisawa, T | 1 |
| Miyazaki, Y; Ogawa, K; Ozawa, T; Satake, T; Sugiyama, S | 1 |
| Hirakawa, S; Ito, H | 1 |
| Aomine, M; Arita, M; Imanishi, S; Kiyosue, T | 1 |
| Taira, N; Yanagisawa, T | 1 |
| Fujiwara, R; Hayashi, T; Kutsumi, Y; Miyabo, S; Nakai, T; Oida, K; Tamai, T | 1 |
| Cogolludo, AL; Pérez-Vizcaíno, F; Tamargo, J; Villamor, E | 1 |
| Baba, T; Katagiri, T; Kikushima, S; Kobayashi, Y; Miyata, A; Tanno, K | 2 |
| Brieger, DB; Freedman, SB; Hawkins, R; Rajaratnam, R | 1 |
| Chang, MS; Chen, SA; Cheng, JJ; Hung, CR; Kaun, P; Lee, SH; Lin, FY; Yu, WC | 1 |
| Horita, Y; Mizogami, M; Shimo, K; Taguchi, T | 1 |
| Adachi, T; Asano, T; Katagiri, T; Kawamura, M; Kobayashi, Y; Obara, C; Ryu, S; Yazawa, T | 1 |
| Ostrovskiĭ, IuP; Sidorenko, GI | 1 |
| Iwase, T; Sakamoto, H; Tamaki, S; Tsubokawa, A; Ueda, K | 1 |
| Alfayoumi, F; Geller, M; Gradman, A; Srinivasan, V | 1 |
| Furukawa, H; Iwasaki, K; Samukawa, M | 1 |
| Cheon, WS; Cho, GY; Choi, YJ; Kim, EJ; Kim, MK; Kim, SH; Park, WJ; Rhim, CY | 1 |
| Fujiwara, H; Hirose, T; Iwama, M; Kojima, T; Matsuo, H; Minatoguchi, S; Ono, K; Segawa, T; Takahashi, H; Warita, S; Watanabe, S; Watanabe, T | 1 |
| Hayashi, T; Ichikawa, M; Iwata, A; Lim, YJ; Mishima, M; Nakata, T | 1 |
| Tan, KT | 1 |
| Bernal, JM; Cubeddu, RJ; Don, CW; Kiernan, GD; Kiernan, TJ; Ruggiero, NJ; Witzke, C; Yan, BP | 1 |
| Bers, DM; Diecke, S; Gong, T; Knowles, JW; Lan, F; Lee, AS; Liang, P; Nguyen, PK; Robbins, RC; Sallam, K; Sanchez-Freire, V; Wang, PJ; Wang, Y; Wu, JC | 1 |
3 review(s) available for verapamil and nicorandil
| Article | Year |
|---|---|
[The no-reflow phenomenon and its clinical significance].
Topics: Adenosine; Angioplasty, Balloon, Coronary; Atherectomy; Coronary Angiography; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Heart Failure; Hospital Mortality; Humans; Microvascular Angina; Myocardial Infarction; Nicorandil; Platelet Glycoprotein GPIIb-IIIa Complex; Risk Factors; Stents; Vasodilator Agents; Verapamil | 2002 |
The no-reflow phenomenon: epidemiology, pathophysiology, and therapeutic approach.
Topics: Adenosine; Animals; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Echocardiography; Humans; Microcirculation; Myocardial Infarction; Myocardial Reperfusion Injury; Nicorandil; Single-Chain Antibodies; Thrombolytic Therapy; Vascular Patency; Vasodilator Agents; Verapamil | 2005 |
The no-reflow phenomenon in the coronary circulation.
Topics: Adenosine; Animals; Coronary Circulation; Diltiazem; Humans; Nicardipine; Nicorandil; Nitroprusside; No-Reflow Phenomenon; Prostheses and Implants; Vasodilator Agents; Verapamil | 2009 |
5 trial(s) available for verapamil and nicorandil
| Article | Year |
|---|---|
Attenuation of anti-ischemic efficacy during chronic therapy with nicorandil in patients with stable angina pectoris.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Cross-Over Studies; Diltiazem; Double-Blind Method; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Time Factors; Verapamil | 1999 |
Effect of intracoronary nicorandil administration on preventing no-reflow/slow flow phenomenon during rotational atherectomy.
Topics: Aged; Angina Pectoris; Atherectomy, Coronary; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Female; Humans; Male; Middle Aged; Myocardial Ischemia; Nicorandil; Recurrence; Vasodilator Agents; Verapamil | 2002 |
Comparison of the effects of nicorandil versus verapamil on the incidence of slow flow/no reflow during rotational atherectomy.
Topics: Aged; Anticoagulants; Atherectomy, Coronary; Biomarkers; Coronary Circulation; Coronary Disease; Creatine Kinase; Female; Heparin; Humans; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Prospective Studies; Recurrence; Treatment Outcome; Troponin T; Vasodilator Agents; Verapamil | 2006 |
Comparative study of nicorandil and a spasmolytic cocktail in preventing radial artery spasm during transradial coronary angiography.
Topics: Coronary Angiography; Coronary Artery Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Nicorandil; Prospective Studies; Radial Artery; Spasm; Vasodilator Agents; Verapamil | 2007 |
Prevention of no-reflow/slow-flow phenomenon during rotational atherectomy--a prospective randomized study comparing intracoronary continuous infusion of verapamil and nicorandil.
Topics: Aged; Atherectomy, Coronary; Coronary Angiography; Coronary Artery Disease; Coronary Restenosis; Coronary Vessels; Drug Therapy, Combination; Electrocardiography; Female; Follow-Up Studies; Humans; Infusions, Intra-Arterial; Male; Nicorandil; Prospective Studies; Treatment Outcome; Vasodilator Agents; Verapamil | 2007 |
26 other study(ies) available for verapamil and nicorandil
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Circumstantial evidence for increased potassium conductance of membrane of cardiac muscle by 2-nicotinamidoethyl nitrate (SG-75).
Topics: Animals; Atropine; Depression, Chemical; Dogs; Female; In Vitro Techniques; Male; Membrane Potentials; Methacholine Compounds; Myocardial Contraction; Niacinamide; Nicorandil; Nitrates; Papillary Muscles; Perfusion; Potassium; Refractory Period, Electrophysiological; Ventricular Fibrillation; Verapamil | 1979 |
Role of intracellular Ca2+ and the calmodulin messenger system in pepsinogen secretion from isolated rabbit gastric mucosa.
Topics: Animals; Calcium; Calmodulin; Carbachol; Colforsin; Dose-Response Relationship, Drug; Gastric Mucosa; Niacinamide; Nicorandil; Organ Culture Techniques; Pepsinogens; Rabbits; Second Messenger Systems; Sincalide; Sulfonamides; Verapamil | 1992 |
Nicorandil is a potent dilator of endothelin-induced vascular contraction.
Topics: Animals; Aorta; Calcium; Dose-Response Relationship, Drug; Endothelins; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicardipine; Nicorandil; Rats; Rats, Inbred Strains; Vasoconstriction; Vasodilator Agents; Verapamil | 1990 |
Examination of the direct effects of nicorandil, verapamil, propranolol, and nitroglycerin on the hypoxic canine myocardium.
Topics: Animals; Coronary Disease; Dogs; Female; Hemodynamics; In Vitro Techniques; Male; Myocardium; Niacinamide; Nicorandil; Nitroglycerin; Perfusion; Propranolol; Vasodilator Agents; Verapamil | 1987 |
Effects of nicorandil and verapamil, antianginal agents, on plasma digoxin concentrations in rats and dogs.
Topics: Animals; Blood Pressure; Digoxin; Dogs; Drug Interactions; Female; Heart Rate; Male; Niacinamide; Nicorandil; Rats; Rats, Inbred Strains; Vasodilator Agents; Verapamil | 1987 |
[Vasorelaxing action of nicorandil, in comparison with nitroglycerin and Ca antagonists].
Topics: Animals; Aorta; Aorta, Thoracic; Calcium Channel Blockers; Diltiazem; Drug Interactions; Male; Niacinamide; Nicorandil; Nitroglycerin; Norepinephrine; Prazosin; Rats; Rats, Inbred Strains; Vasodilator Agents; Verapamil | 1986 |
[Influence of antianginal drugs on Lypressin induced T-wave enhancement in the electrocardiogram of the rat].
Topics: Administration, Oral; Angina Pectoris; Animals; Coronary Vasospasm; Electrocardiography; Hypoxia; Isosorbide Dinitrate; Lypressin; Male; Molsidomine; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Rats; Rats, Inbred Strains; Verapamil | 1986 |
[Role of calcium ion on pepsinogen secretion by organ culture of rabbit gastric mucosa].
Topics: Animals; Calcium; Gastric Mucosa; Male; Niacinamide; Nicorandil; Organ Culture Techniques; Pepsinogens; Rabbits; Verapamil | 1986 |
Mechanisms of tetraethylammonium-induced contraction in the canine coronary artery.
Topics: 4-Aminopyridine; Aminopyridines; Animals; Calcium; Cesium; Chlorides; Coronary Vessels; Dogs; Female; In Vitro Techniques; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Phenylephrine; Potassium; Tetraethylammonium Compounds; Vasodilator Agents; Verapamil | 1986 |
Abolition of spontaneous rhythmic contractions of isolated monkey coronary arteries by diltiazem, nifedipine, verapamil and nicorandil but not by nitroglycerin.
Topics: Animals; Calcium Channel Blockers; Coronary Vessels; Diltiazem; Erythrocebus patas; Female; In Vitro Techniques; Macaca mulatta; Male; Muscle Contraction; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Verapamil | 1985 |
Vasodilative effect of nicorandil on coronary artery.
Topics: Animals; Coronary Vessels; Dinoprost; Dogs; Female; Male; Muscle Relaxation; Niacinamide; Nicorandil; Potassium; Prostaglandins F; Vasodilator Agents; Verapamil | 1985 |
Effects of vasodilators on the systemic capacitance vessels, a study with the measurement of the mean circulatory pressure in dogs.
Topics: Animals; Blood Pressure; Blood Vessels; Blood Volume; Cardiac Output; Diltiazem; Dogs; Heart Rate; Isosorbide Dinitrate; Molsidomine; Niacinamide; Nicorandil; Nifedipine; Nitroglycerin; Prazosin; Sydnones; Trapidil; Vascular Resistance; Vasodilator Agents; Venous Pressure; Verapamil | 1984 |
Effects of SG-75 (nicorandil) on electrical activity of canine cardiac Purkinje fibers: possible increase in potassium conductance.
Topics: Action Potentials; Animals; Atropine; Barium; Dogs; Electrophysiology; Female; Heart Conduction System; Ion Channels; Male; Niacinamide; Nicorandil; Potassium; Purkinje Fibers; Solutions; Stress, Mechanical; Verapamil | 1983 |
Effect of 2-nicotinamidethyl nitrate (SG-75) on the membrane potential of left atrial muscle fibres of the dog. Increase in potassium conductance.
Topics: Animals; Atropine; Chlorides; Dogs; Drug Interactions; Heart; In Vitro Techniques; Membrane Potentials; Methacholine Compounds; Neural Conduction; Niacinamide; Nicorandil; Nitrates; Ouabain; Potassium; Vasodilator Agents; Verapamil | 1980 |
Effects of nicorandil on cell proliferation and cholesteryl ester accumulation in arterial smooth muscle cells in culture.
Topics: Animals; Aorta, Thoracic; Calcium Channels; Cell Division; Cells, Cultured; Cholesterol; Cholesterol Esters; Diltiazem; DNA; Male; Muscle, Smooth, Vascular; Niacinamide; Nicorandil; Rats; Rats, Wistar; Vasodilator Agents; Verapamil | 1993 |
Role of K+ channel opening and stimulation of cyclic GMP in the vasorelaxant effects of nicorandil in isolated piglet pulmonary and mesenteric arteries: relative efficacy and interactions between both pathways.
Topics: Animals; Cromakalim; Cyclic GMP; Enzyme Activation; Enzyme Inhibitors; Glyburide; Guanylate Cyclase; In Vitro Techniques; Male; Mesenteric Arteries; Niacinamide; Nicorandil; Nitroprusside; Potassium Channels; Pulmonary Artery; Swine; Vasodilator Agents; Verapamil | 1998 |
Effects of nicorandil, a potassium channel opener, on idiopathic ventricular tachycardia.
Topics: Adenosine Triphosphate; Adolescent; Adult; Anti-Arrhythmia Agents; Calcium Channel Blockers; Chromatography, High Pressure Liquid; Electrocardiography; Female; Humans; Infusions, Intravenous; Male; Middle Aged; Nicorandil; Potassium Channels; Tachycardia, Ventricular; Treatment Outcome; Verapamil | 1998 |
Slow ventricular tachycardia located in the epicardium of the left ventricular base and characterized by effects of adenosine triphosphate, nicorandil and verapamil.
Topics: Adenosine Triphosphate; Adult; Anti-Arrhythmia Agents; Heart Ventricles; Humans; Male; Nicorandil; Pericardium; Tachycardia, Ventricular; Ventricular Premature Complexes; Verapamil | 1998 |
Change of atrial refractory period after short duration of rapid atrial pacing: regional differences and possible mechanisms.
Topics: Adenosine Triphosphatases; Animals; Anti-Arrhythmia Agents; Atrial Function; Calcium Channels; Cardiac Pacing, Artificial; Dogs; Electrocardiography; Heart Rate; Nicorandil; Potassium Channels; Premedication; Ryanodine; Sotalol; Verapamil | 1999 |
Stunned myocardium after hip arthroplasty.
Topics: Aged; Anti-Arrhythmia Agents; Arthroplasty, Replacement, Hip; Coronary Angiography; Female; Humans; Myocardial Stunning; Nicorandil; Tomography, Emission-Computed, Single-Photon; Verapamil | 2000 |
Ventricular arrhythmias with left bundle branch block pattern and inferior axis: assessment of their mechanisms on the basis of response to ATP, nicorandil and verapamil.
Topics: Adenosine Triphosphate; Adult; Anti-Arrhythmia Agents; Biological Transport, Active; Bundle-Branch Block; Calcium Channel Blockers; Calcium Channels, L-Type; Cardiotonic Agents; Drug Resistance; Electrocardiography; Exercise Test; Female; Heart Conduction System; Humans; Ion Transport; Isoproterenol; Male; Middle Aged; Models, Cardiovascular; Nicorandil; Potassium; Potassium Channels; Purkinje Fibers; Tachycardia, Ventricular; Ventricular Premature Complexes; Verapamil | 2000 |
Intracoronary nicorandil relieves multiple coronary vasospasm with hemodynamic collapse.
Topics: Coronary Vasospasm; Female; Hemodynamics; Humans; Isosorbide Dinitrate; Middle Aged; Nicorandil; Shock; Ultrasonography; Vasodilator Agents; Verapamil | 2008 |
Pathology, imaging and treatment of cardiac microvascular obstruction.
Topics: Adenosine; Coronary Vessels; Humans; Magnetic Resonance Angiography; Myocardial Infarction; Nicorandil; Nitroprusside; Vasodilator Agents; Verapamil | 2010 |
Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity.
Topics: Action Potentials; Cardiomyopathy, Dilated; Cardiomyopathy, Hypertrophic, Familial; Cell Differentiation; Cell Line; Cell Size; Cisapride; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Embryoid Bodies; Embryonic Stem Cells; Gene Expression Profiling; Genetic Predisposition to Disease; HEK293 Cells; Humans; In Vitro Techniques; Induced Pluripotent Stem Cells; Ion Channels; Kidney; Long QT Syndrome; Myocytes, Cardiac; Myofibrils; Nicorandil; Patch-Clamp Techniques; Quinazolines; Verapamil | 2013 |